Kyowa Kirin secures FDA approval for Crysvita dosing update
Following the update, healthcare providers can increase both the dose and frequency of Crysvita for XLH patients after treatment.
Drug Development
Zydus to acquire Assertio in $166m deal
Coya Therapeutics secures FDA fast track status for COYA 302
Pfizer receives EC approval for Hympavzi to treat haemophilia
UAE approves AstraZeneca’s Baxfendy for hypertension
Isomorphic Labs receives $2.1bn for AI drug development
Partner Therapeutics secures FDA approval for Bizengri
ACROBiosystems upgrades HEK293 licence solution for R&D compliance
